Quiz
The Control of Noncommunicable Diseases in Latin America and the Caribbean
Anselm Hennis, MD, MSc, PhD, FRCP, FACP Johns Hopkins University
Director, Noncommunicable Diseases and Mental Health
Pan American Health Organization / World Health Organization
The material in this video is subject to the copyright of the owners of the material and is being provided for educational purposes under rules of fair use for registered students in this course only. No additional copies of the copyrighted work may be made or distributed.
Noncommunicable Disease (NCD) Burden and Risk Factors
Section A
Global NCD Burden: Total Deaths by Broad Cause Group, by WHO Region, World Bank Income Group and by Sex, 2008
3 Source: Alwan, A., & World Health Organization. (2011). Global status report on noncommunicable diseases 2010. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/nmh/publications/ncd_report2010/en/. Accessed April 22, 2015.
AFR indicates African Region; AMR, Region of the Americas; EMR, Eastern Mediterranean Region; EUR, European Region; SEAR, South- East Asia Region; and WPR, Western Pacific Region.
Region of the Americas: Main Causes of Death (2010)
Source: Pan-American Health Organization (PAHO) Regional Observatory Database. Available at: http://www.paho.org/hq/index.php?option=com_ content&view=article&id=5542&Itemid=2391&lang =e. Accessed April 22, 2015. 4
The Facts in the Americas: Disease Burden
149 million smokers 25% – 30% adults with elevated
blood pressure 25% persons >15 years old obese
Approximately 200 million people living with an NCD in the Americas
36% deaths occur below age 70 years
Total NCD deaths (2010) 3.9 M
45% Cardio- vascular diseases
Cancer 30%
Diabetes 8%
Other NCDs 7%
Chronic resp.
disease 10%
5
Cardiovascular Diseases
6
45% Cardio- vascular diseases
Cancer 30% Diabetes 8%
Other NCDs 7%
Chronic resp.
disease 10%
Hypertension Prevalence by Gender in Latin America and the Caribbean
Source: Burroughs Peña, M. S., Mendes Abdala, C. V., Silva, L. C., & Ordúñez, P. (2012). Usefulness for surveillance of hypertension prevalence studies in Latin America and the Caribbean: the past 10 years. Revista Panamericana De Salud Pública = Pan American Journal of Public Health, 32(1), 15–21.
48.7 37.7
33.1 27.5 27.3
23.8 23.4
20.0 14.6 14.4
11.2 7.2
46.5 21.7
37.3 22.9
20.7 26.8
20.0 25.0
12.4 10.7
12.1 10.1
60.0 40.0 20.0 0.0 20.0 40.0 60.0
HAITI ARG
GUAD VEN CHI BRA CUB
MART COL PER MEX ECU
Female Male
7
Proportion of Deaths Due to Cardiovascular Diseases by Income Group in the Americas
Source: PAHO/WHO. (2012).
Cerebrovascular diseases Ischemic heart disease
Low and lower- middle income
High income
Upper- middle income
Upper- middle income
High income
Low and lower- middle income
8
Public policy and advocacy
Surveillance Health promotion and disease prevention
Integrated control of chronic diseases and their risk factors
Multisectoral action and social determinants
Universal coverage and equitable access to health services
Integration and sustainability of interventions
Integration of information systems
Mortality records and risk factor surveillance
Health services performance and economic assessments
Information sharing Technical capacity
Tobacco Salt intake Healthy diet Physical activity Alcohol
Competencies of health personnel
Primary care, population risk stratification, and integrated health services networks
Chronic care model Hypertension and individual
total cardiovascular disease risk
Quality and efficiency of clinical services
Acute coronary syndrome and stroke
Priorities for Cardiovascular Health in the Americas: Key Messages for Policymakers (2011)
Source: Ordúñez García P, Campillo Artero C. (2011). Regional Consultation. Priorities for cardiovascular health in the Americas. Key messages for policymakers. Washington: Pan-American Health Organization. Available at: http://www1.paho.org/priorities/pdf-en/book.pdf. Accessed March 8, 2015. 9
Cancer
10
45% Cardio- vascular diseases
Cancer 30% Diabetes 8%
Other NCDs 7%
Chronic resp.
disease 10%
Lung Cancer
Source: PAHO. (June 19, 2013). Epidemiology of Lung Cancer in the Americas, 2014. Retrieved April 22, 2015, from http://www.paho.org/hq/index.php?option=com_docman&task=doc_details&gid=22070&Itemid=270&lang=en. 11
Lung cancer is the third most common cancer and the leading cause of cancer deaths in the Americas, with more than 324,000 new cases and nearly 262,000 deaths each year.
Proportion of new cases and deaths from lung cancer in the Americas, 2012
Prostate Cancer
Source: PAHO. (May 21, 2013). Epidemiology of Prostate Cancer in the Americas, 2014. Retrieved April 22, 2015, from http://www.paho.org/hq./index.php?option=com_docman&task=doc_details&gid=21593&Itemid=270&lang=en. 12
Prostate cancer is the most common cancer in men in the Americas, and the second leading cause of cancer deaths. There are more than 412,000 new cases and 85,000 deaths each year in the Americas.
Proportion of new cases and deaths from prostate cancer in the Americas
Breast Cancer
Source: PAHO. (October 10, 2014). Epidemiology of Breast Cancer in the Americas. Retrieved April 22, 2015, from http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&Itemid=270&gid=21834&lang=fr. 13
Breast cancer is the most common cancer type in women and the second leading cause of cancer deaths among women in the Americas. There are more than 408,200 new cases and more than 92,000 deaths from
breast cancer annually in the Americas.
Proportion of new cases and deaths from breast cancer in the Americas, 2012
In Latin America and the Caribbean, 27% of new cancer cases and 15% of cancer deaths are due to breast cancer. Similarly, in North America, 30% of new cases and 15% of cancer deaths are caused by breast cancer.
Cervical Cancer in the Americas
North America: 12,300 new cases per year 4,500 deaths per year
Latin America and the Caribbean: 68,000 new cases per year 31,400 deaths per year
Source: Fuente: Globocan 2008. 14
Promoting policies for tobacco control, alcohol, healthy eating, and physical activity
Increasing immunization against infections that cause certain types of cancer, such as cervical cancer and liver cancer, and improving protection from carcinogens at the workplace and in the environment
Increasing access to screening programs for early detection—for example, of cervical cancer and breast cancer
Increasing cancer patients’ access to timely diagnosis and appropriate treatment
Increasing access to palliative care for patients
PAHO’s Work
15
Diabetes
16
45% Cardio- vascular diseases
Cancer 30%
Diabetes 8%
Other NCDs 7%
Chronic resp.
disease 10%
Prevalence (%) of Diabetes Among Adults in the Americas
Source: Pan Am J Public Health 10(5), 2001; PAHO, CAMDI, Haiti (Diabetic Medicine); USA (Cowie, Diabetes Care); Canada, Ontario Lipscombe & Hux 2007; US Mexico Border Project. Jamaica (Jamaica Health and Lifestyle Survey, 2008); C Rica, STEPS CR 2011
6 7 7 8 8 8 8 8 9 9 9 9 9 9
10 10 10 10 11 11
12 12 13
15 16 16 16
Honduras Urban Peru
Haiti US Whites
Brazil Jamaica
Colombia Guatemala
Bolivia Suriname
Mexican Americans Nicaragua
Canada (ON) Chile
US Total Argentina Paraguay US Blacks
Mexico C Rica Cuba
Belize Trinidad/Tobago
Mexican Side of US-Mexico… US-Mexico Border Region
US Side of US-Mexico Border Barbados
17
Estimated Prevalence of Diabetes Mellitus (Millions) per Subregion, 2011- 2030
25.1
37.7
62.8
39.9
51.2
91.1
0
10
20
30
40
50
60
70
80
90
100
America Central/Sur
Norte Am/Caribe Las Americas
2011
2030
18
Risk Factor and Diabetes Survey conducted across Central America
Interventions to improve management of diabetes implemented in Mexico, Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Antigua, Anguilla, Grenada, Belize, Guyana, Suriname, and St. Lucia
Course on Evidence-Based Chronic Illness Care implemented twice in collaboration with the University of Miami, and in Argentina, Chile, and Colombia
Implementation of the Chronic Care Model collaboration ongoing in Mexico, Argentina, Chile, Brazil, the Caribbean(10 countries), the Dominican Republic, Paraguay, and Honduras
Main Achievements
19
The diabetes epidemic is a major public health challenge: Rising burden of obesity Management requirement for multidisciplinary approaches
Quality of care for diabetes and other chronic diseases is suboptimal in most of the countries with available data
Lack of integrated approaches, application of evidence-based clinical practice guidelines, suboptimal self-management support, absence of clinical information system, and system orientation to continuous evidence-based care
Main Challenges
20
The material in this video is subject to the copyright of the owners of the material and is being provided for educational purposes under rules of fair use for registered students in this course only. No additional copies of the copyrighted work may be made or distributed.
Addressing NCD Risk Factors
Section B
Protective Actions: Addressing NCD Risk Factors
NCDs
Tobacco consumption
Harmful use of alcohol
Unhealthy diet
Lack of physical activity
2
Current Prevalence of Adult Smokers: WHO Regions
Source: Fonte: Global Health Risks, 2009.
0% 5% 10% 15% 20% 25% 30% 35%
World
EURO
WPRO
AMRO
SEARO
EMRO
AFRO
26%
33%
32%
24%
21%
18%
9%
3
AFRO indicates African Region; EMRO, Eastern Mediterranean Region; SEARO, South-East Asia Region; AMRO, Americas Region; WPRO, Western Pacific Region; and EURO, European Region.
The “Gold” Standard: Tobacco Control
WHO Framework Convention on Tobacco Control Legally binding international treaty Ratified by 176 countries
• 29 in the Americas A baseline, not a goal, for tobacco control
measures
Source: Fuente: Informe OMS sobre la Epidemia de Tabaquismo, 2008. 4
FCTC Implementation: MPOWER
MPOWER strategies: M: Monitor tobacco use and prevention policies P: Protect people from tobacco smoke O: Offer help to quit smoking W: Warn about the dangers of tobacco E: Enforce bans on tobacco advertising, promotion,
and sponsorship R: Raise taxes on tobacco
Source: World Health Organization, & Research for International Tobacco Control (Eds.). (2008). WHO report on the global tobacco epidemic, 2008: the MPOWER package. Geneva: World Health Organization. Available at: http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf. Accessed April 22, 2015. 5
Countries With 100% Smoke-Free Laws (WHO FCTC Art. 8 Compliant)
Countries with 100% smoke-free laws:
1. Uruguay (2005/2008) 2. Panama (2008) 3. Canada (2008) 4. Guatemala (2008) 5. Colombia (2008/2009) 6. Trinidad y Tobago (2009) 7. Perú (2010) 8. Honduras (2010)
9. Barbados (2010) 10. Venezuela (2011) 11. Argentina (2011) 12. Ecuador (2011) 13. Brasil (2011) 14. Costa Rica (2012) 15. Chile (2013) 16. Surinam (2013)
6
Countries With Laws That Establish Health Warnings of 50%+ With Images (WHO FCTC Art. 11 Compliant)
7
Countries with laws that establish health warnings of 50%+ with images:
1. Canada 2. Brasil 3. Cuba (sin imagen) 4. Chile 5. Panama 6. Uruguay 7. Jamaica (sin imagen) 8. Venezuela 9. Bolivia 10. Colombia
11. Mexico 12. Estados Unidos 13. Peru 14. Honduras 15. Nicaragua 16. Argentina 17. Ecuador 18. El Salvador 19. Costa Rica 20. Surinam
Countries With Laws That Establish a Total Ban of Advertisement, Promotion, and Sponsorship (WHO FCTC Art. 13 Compliant)
8
Countries with laws that establish a total ban of advertisement, promotion, and sponsorship:
1. Panamá (2008) 2. Colombia (2009) 3. Brasil (2011) 4. Chile (2013) 5. Surinam (2013)
WHO Framework Convention on Tobacco Control has 177 parties worldwide (29 in the Americas region)
Seventeen countries of the region are 100% smoke-free in enclosed public spaces and workplaces and on public transportation
Five countries of the region have a total ban on tobacco advertisement, promotion and sponsorship
Seventeen countries of the region have graphic health warnings on packaging of tobacco products of 50% or more of the principal surfaces
Some countries of the region have raised tobacco taxes, with earmarks for public health
WHO Main Achievements
9
Challenges include … Tobacco industry interference Lack of political will at country level to comply with the mandates of the WHO
FCTC Lack of human and financial resources
Only six countries have recent information that is representative and periodically collected (at least every five years) for young people and adults
Only two countries, Panama and Costa Rica, have reached the recommended level in tax increase in proportion to the final cost of the tobacco products
Main Challenges
10
Main Psychoactive Substances Accountable for Treatment Entry Globally, 2008 (WHO, 2010)
11
Alcohol is the leading risk factor among 15- to 49-year-olds in 26 countries: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil,
Canada, Colombia, Costa Rica, Dominica, Ecuador, El Salvador, Grenada, Guatemala, Guyana, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Lucia, Saint Vincent and the Grenadines, United States, Uruguay, Venezuela
Harmful Use of Alcohol
12
Regional plan of action adopted in 2011
Virtual courses on alcohol policy and brief interventions
Collaborative research and publications (various)
Main Achievements
13
Unregulated market and marketing
Need to build capacity for alcohol policy making
Need for political commitment to reduce alcohol consumption
Interference of the alcohol industry
Need for increased knowledge base at country level (surveillance, research)
Limited financial resources
Main Challenges
14
NCD Risk Factors: The Case of Consumption of Sugary Drinks
Source: Brownell K., et.al. (2011). Unpublished observations. 15
Sugar Consumption in the Past 10 Years and Risk of Diabetes
Source: Basu, Stuckler, et.al. (2012). 16
Marketing and Risk Factors of NCDs
17 Source: The Coca-Cola Company reinforces commitment in the fight against obesity. Retrieved April 23, 2015, from http://www.coca-colacompany.com/press-center/press- releases/the-coca-cola-company-reinforces-its-commitment-to-help-america-in-the-fight-against-obesity
“Coming Together” “Be OK”
UN High-Level Meeting on NCDs
Best buy:
18
Country Survey year (mg/day) g/day Source
Argentina 2004 12 g/day Encuesta nacional de nutrición y salud (http://www.msal.gov.ar/htm)
Brazil 2003-2004 (4500 mg/day) 11.25 g/day Sarno, Moreira Claro, et al.
Chile 2009 (3600 mg/day) 9.0 g/day Encuesta Nacional de Salud 2010 (www.minsal.cl)
U.S. 2005-2006 (3466 mg/day) 8.66 g/day NHANES study
Barbados 1991-1994 6.78±3.15 Cooper, et al. (Am J Public Health 1997;87:160–68)
Canada 1990-1999 7.98±13.80 IOM citing Health Canada (Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulphate)
Jamaica 1994-1995 8.45±6.62 Cooper, et al. (Am J Public Health 1997;87:160–68)
Panama 12.35±9.15 Hollenberg , et al. (Hypertension 1997;29:171–76)
St. Lucia 1991-1994 8.58±3.68 Cooper, et al. (Am J Public Health 1997;87:160–68)
Venezuela 5.32 Negretti de Bratter (Metal Ions in Biology and Medicine)
Salt Intake Data in the Region
19 Adapted from: Brown, I. J., Tzoulaki, I., Candeias, V., & Elliott, P. (2009). Salt intakes around the world: implications for public health. International Journal of Epidemiology, 38(3), 791–813. http://doi.org/10.1093/ije/dyp139 (updated with recent information from the region)
Estimated Road Traffic Death Rates per 100,000 Population in the Americas, by Country, 2010
Road traffic injuries caused an estimated 149,992 deaths in 2010
Among subregions, the road traffic death rate per 100,000 population ranges from 11.0 in North America to 22.2 in the Latin Caribbean
The average rate for the Region was 16.1 deaths per 100,00 population
Source: PAHO. Road Safety Facts in the Region of the Americas, 2013. Available at: http://www.who.int/violence_injury_prevention/road_safety_status/2013/report/factsheet_paho_en.pdf. Accessed April 22, 2015. 20
Proportion of Reported Road Traffic Deaths in the Region of the Americas, by Type of Road User and Subregion, 2010
Source: PAHO. Road Safety Facts in the Region of the Americas, 2013. Available at: http://www.who.int/violence_injury_prevention/road_safety_status/2013/report/factsheet_paho_en.pdf. Accessed April 22, 2015. 21
The material in this video is subject to the copyright of the owners of the material and is being provided for educational purposes under rules of fair use for registered students in this course only. No additional copies of the copyrighted work may be made or distributed.
What Do We Do?
Section C
Economies
• Reduced labor supply • Reduced labor outputs (e.g.,
cost of absenteeism) • Additional costs to employers
(e.g., productivity, insurance) • Lower returns on human capital
investments • Lower tax revenues • Increased public health and
social welfare expenditures
Health systems
• Increased consumption of NCD- related healthcare
• High medical treatment costs (per episode and over time)
• Demand for more effective treatments (e.g., cost of technology and innovation)
• Health system adaptation (e.g., organization, service delivery, financing) and adaptation costs
Households and individuals
• Reduced well-being • Increased disabilities • Premature deaths • Household income decrease,
loss, or impoverishment • Higher health expenditures,
including catastrophic spending • Savings and assets loss • Reduced opportunities
NCDs Have a Significant Impact on Economies, Health Systems, and Households
Source: World Bank analysis by the authors in “Chronic Emergency: Why NCDs Matter.” Health, Nutrition, and Population Discussion Paper. 2011. Washington DC: World Bank. 2
Country productivity and competitiveness
Fiscal pressures
Health outcomes
Poverty, inequity, and opportunity loss
Example impact areas
The Estimated Global Costs Will Multiply Almost Exponentially: Output Losses Will Speed Up Over Time
3 Source: Bloom, D.E., Cafiero, E.T., Jané-Llopis, E., et al. (2011). The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum. Available at: http://www.hsph.harvard.edu/program-on-the-global-demography-of-aging/WorkingPapers/2012/PGDA_WP_87.pdf. Accessed April 22, 2015.
Health Spending Projections by Chronic Condition in Brazil, 2008–2050
Source: Glassman, A., Gaziano, T. A., Buendia, C. P. B., & de Aguiar, F. C. G. (2010). Confronting the chronic disease burden in Latin America and the Caribbean. Health Affairs, 29(12), 2142–2148. http://doi.org/10.1377/hlthaff.2010.1038 © 2010 by Project HOPE - The People-to-People Health Foundation, Inc. 4
NCDs: Global and Regional Context
5
UN General Assembly, 2011
Commitments from Heads of State and
Government
World Health Assembly, 2012
Adopt a global target of 25% reduction in premature
mortality from NCDs by 2025
World Health Assembly, May
2013
WHO Global NCD Action Plan 2013- 2020, including 9 global targets and
25 indicators
PAHO Directing Council,
September 2013
PAHO Regional NCD Action Plan 2013- 2020, fully aligned with WHO Global
Action Plan
UN General Assembly NCD Review 2014: Review and assessment of the United Nations General Assembly of the progress achieved in
the prevention and control of NCDs
UN High-Level Meeting (UNHLM) Political Declaration calls on Member States to: Respond to the challenge with a whole-government and whole-society effort Reduce risk factors and create health-promoting environments Strengthen national policies and health systems Strengthen international cooperation, including collaborative partnerships Support research and development Strengthen monitoring and evaluation Follow up—UNGA 2014
UN High-Level Meeting Political Declaration
6
What Have We Gained With the UNHLM?
UNHLM Declaration
Political commitment
Raise awareness of the problem
Mobilization of resources
Coordination of efforts
Inclusion of other sectors
Increased accountability
7
What Has Happened Since the UN Political Declaration on NCDs in 2011?
WHO Global NCD Action Plan 2013-2020 (and one WHO Plan on NCDs)
WHO Comprehensive implementation plan on maternal, infant, and young child nutrition, 2012-2025
Global coordination mechanism for the prevention and control of NCDs
UN Interagency Task Force
Source: World Health Organization. (2013). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Available at: http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf?ua=1. Accessed April 22, 2015. 8
1. A 25% relative reduction in risk of premature mortality from CVDs, cancer, diabetes, chronic respiratory diseases
2. At least 10% relative reduction in the harmful use of alcohol, as appropriate, within the national context
3. A 10% relative reduction in prevalence of insufficient physical activity 4. A 30% relative reduction in mean population intake of salt/sodium 5. A 30% relative reduction in prevalence of current tobacco use in persons aged 15+ years 6. A 25% relative reduction in the prevalence of raised blood pressure or contain the prevalence
of raised blood pressure, according to national circumstances 7. Halt the rise in diabetes and obesity 8. At least 50% of eligible people receive drug therapy and counselling (including glycaemic
control) to prevent heart attacks and strokes 9. An 80% availability of the affordable basic technologies and essential medicines, including
generics, required to treat major NCDs in both public and private facilities
Nine Global Voluntary Targets by 2025
9 Source: WHO | About 9 voluntary global targets. (n.d.). Retrieved April 23, 2015, from http://www.who.int/nmh/ncd-tools/definition-targets/en/.
PAHO Plan of Action for the Prevention and Control of Noncommunicable Diseases
Adopted October 3, 2013, by Ministers of Health of the Americas
First line of action: Multisectoral policies and partnerships
for NCD prevention and control, including civil society, academia, media, and voluntary associations
Source: PAHO. (2013). CD52/7, Rev. 1: Plan of Action for the Prevention and Control of Noncommunicable Diseases. US1.1. Available at: http://iris.paho.org/xmlui/handle/123456789/4400. Accessed April 22, 2015. 10
NCD Regional Strategy 2012 and Plan of Action with regional targets and indicators 2013-2019 Aligned with WHO Global NCD Plan
Technical cooperation with Member States
Continue advocacy in global forums: Social Determinants, G8/G20, Summit of the Americas, etc.
Promote multisector partnerships Pan American Forum for Action on NCDs
Broader engagement in NCDs with other regional UN agencies
What Has Happened Regionally Since the UN Political Declaration on NCDs in 2011?
11
Focus of PAHO’s NCD Plan of Action 2013-2019
Four diseases: CVD, cancer, diabetes, CRD
Four risk factors: tobacco, diet, alcohol, physical
inactivity Other regional issues:
obesity, mental health, CKD
NCDs as development issue Whole-government, whole-society
approach
NCDs in social protection schemes
and UHC
Protective factors and determinants of
health
Change of model of care within PHC
Access to technology and
medicines
Monitor advances
12
Competing national priorities
Insufficient investment in prevention and control of NCDs
Low regulatory capacity at the national level
Interference from big economic corporations
Complexity of monitoring and reporting systems (reduces country capacity to report progress on NCDs and risk factors)
Failure to comply with international mandates such as WHO FCTC
Challenges of the PAHO NCD Action Plan
13
PAHO Technical Guidelines
14 Source: www.paho.org.
NCD Recommended “Best Buys”
Source: First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control (Moscow, 28-29 April 2011). Discussion Paper: Prevention and Control of NCDs: Priorities for Investment . Available at: http://www.who.int/nmh/publications/who_bestbuys_to_prevent_ncds.pdf. Accessed April 22, 2015.
Risk factor / disease Interventions
Tobacco use
Raise taxes on tobacco Protect people from tobacco smoke Warn about the dangers of tobacco Enforce bans on tobacco advertising
Harmful use of alcohol Raise taxes on alcohol Restrict access to retailed alcohol Enforce bans on alcohol advertising
Unhealthy diet and physical inactivity
Reduce salt intake in food Replace trans-fat with polyunsaturated fat Promote public awareness about diet and physical activity
Cardiovascular disease (CVD) and diabetes
Provide counseling and multidrug therapy (including blood sugar control for diabetes mellitus) for people with medium-high risk of developing heart attacks and strokes (including those who have established CVD) Treat heart attacks (myocardial infarction) with aspirin
Cancer Hepatitis B immunization beginning at birth to prevent liver cancer Screening and treatment of precancerous lesions to prevent cervical cancer
15
The fight against NCDs is not only about individual choices
Best buys already working for tobacco control and can be adapted to the food, beverage, and alcohol industries
Multisectoral approaches are the only way to effectively tackle the NCD epidemic
Conclusion: NCDs, a Shared Responsibility
16
Thank you!
17
Lecture Evaluation
Your feedback is very important and will be used for future revisions. The Evaluation link is available on the lecture page.
18
- A
- B
- C